Overview

• Théo Grataloup, born in 2007 with severe congenital malformations, has undergone over 50 surgeries to address issues with his larynx, esophagus, and respiratory system.
• The family alleges that glyphosate exposure during Sabine Grataloup's early pregnancy, via the herbicide Glyper, caused Théo's malformations.
• This trial, taking place in Vienne, France, on April 3, 2025, is the first globally to address congenital malformations allegedly linked to glyphosate exposure.
• The case highlights the lack of scientific consensus on glyphosate's health effects, raising broader questions about corporate accountability and public health safety.
• Bayer-Monsanto faces potential precedent-setting legal consequences as the court examines the alleged link between glyphosate and birth defects.